Related Experiment Video
Updated: Jun 8, 2025

Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins
Published on: November 30, 2021
3-nitropyridine analogues as novel microtubule-targeting agents
Jean Herman1,2,3,4, Els Vanstreels5, Dorothée Bardiot1
14AZA Biosciences, Leuven, Belgium.
Novel 3-nitropyridine compounds show potent anti-cancer effects by targeting microtubules. While effective against various cancers and lacking myelotoxicity, they still exhibit neurotoxicity.
Area of Science:
- Oncology
- Pharmacology
- Structural Biology
Background:
- Microtubule-targeting agents are crucial anti-cancer drugs.
- Their clinical use is limited by myelotoxicity and neurotoxicity.
Purpose of the Study:
- To identify novel microtubule-targeting agents with improved safety profiles.
- To evaluate the anti-cancer efficacy and mechanism of action of 3-nitropyridine analogues.
Main Methods:
- In vitro and in vivo anti-cancer activity assays.
- Tubulin polymerization inhibition assays.
- X-ray crystallography to determine tubulin-4AZA2996 structure.
Main Results:
- 3-nitropyridines exhibit potent anti-cancer effects across diverse cancer types.
- Compounds induce G2-M cell cycle arrest by inhibiting tubulin polymerization.
- X-ray crystallography reveals binding at the colchicine-site of tubulin.
- In vivo studies in a colon cancer model demonstrate significant tumor growth inhibition.
Conclusions:
- 3-nitropyridine analogues represent a promising new class of microtubule-targeting anti-cancer agents.
- These compounds demonstrate efficacy with reduced myelotoxicity but retain neurotoxicity.
Related Concept Videos
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Destabilization of Microtubules
Assembly of Complex Microtubule Structures
Microtubule Formation
Microtubule Associated Proteins (MAPs)

